MedTrace Logo

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease

NCT06027333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-03-13

No results posted yet for this study

Summary

Patients with fibrotic insterstitial lung disease (ILD) participating in inpatient rehabilitation or in outpatient pulmonary care will be invited to participate in this observational study. Patients will fill out questionnaire regarding quality of life and symptoms at baseline and follow-up (at the end of rehabilitation or after the second outpatient ILD consultation). Additionally, clinical data obtained in clinical routine or for the IIP registry will be used for this project.

The aim is to assess changes in self-efficacy and quality of life over time and to establish a control cohort for a later feasibility study on a educational and self-management intervention (currently in planning).

Conditions

Interventions

BEHAVIORAL

inpatient rehabilitation

This is an uncontrolled observational study on patients undergoing usual care in pulmonary rehabilitation and care

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • Zurich University of Applied Sciences

    collaborator OTHER

  • University of Zurich

    collaborator OTHER

  • Berner Reha Zentrum AG

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-08
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06027333 on ClinicalTrials.gov